GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » CQ Pharmaceutical Holding Co Ltd (SZSE:000950) » Definitions » Beneish M-Score

CQ Pharmaceutical Holding Co (SZSE:000950) Beneish M-Score : -2.32 (As of May. 12, 2024)


View and export this data going back to 1999. Start your Free Trial

What is CQ Pharmaceutical Holding Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.32 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for CQ Pharmaceutical Holding Co's Beneish M-Score or its related term are showing as below:

SZSE:000950' s Beneish M-Score Range Over the Past 10 Years
Min: -3.62   Med: -1.99   Max: 90.2
Current: -2.32

During the past 13 years, the highest Beneish M-Score of CQ Pharmaceutical Holding Co was 90.20. The lowest was -3.62. And the median was -1.99.


CQ Pharmaceutical Holding Co Beneish M-Score Historical Data

The historical data trend for CQ Pharmaceutical Holding Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CQ Pharmaceutical Holding Co Beneish M-Score Chart

CQ Pharmaceutical Holding Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.23 -1.93 -2.27 -2.35 -2.26

CQ Pharmaceutical Holding Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.30 -2.18 -2.44 -2.26 -2.32

Competitive Comparison of CQ Pharmaceutical Holding Co's Beneish M-Score

For the Medical Distribution subindustry, CQ Pharmaceutical Holding Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CQ Pharmaceutical Holding Co's Beneish M-Score Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, CQ Pharmaceutical Holding Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where CQ Pharmaceutical Holding Co's Beneish M-Score falls into.



CQ Pharmaceutical Holding Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of CQ Pharmaceutical Holding Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.95+0.528 * 1.1109+0.404 * 1.0239+0.892 * 1.1195+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9263+4.679 * 0.002175-0.327 * 0.9687
=-2.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was ¥37,993 Mil.
Revenue was 19624.283 + 21735.367 + 17668.704 + 21094.759 = ¥80,123 Mil.
Gross Profit was 1520.813 + 1548.662 + 1344.031 + 1791.329 = ¥6,205 Mil.
Total Current Assets was ¥55,807 Mil.
Total Assets was ¥64,823 Mil.
Property, Plant and Equipment(Net PPE) was ¥2,610 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥2,590 Mil.
Total Current Liabilities was ¥42,265 Mil.
Long-Term Debt & Capital Lease Obligation was ¥6,440 Mil.
Net Income was 102.961 + 137.342 + 3.953 + 347.617 = ¥592 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ¥0 Mil.
Cash Flow from Operations was -3151.359 + 3475.333 + 850.028 + -723.102 = ¥451 Mil.
Total Receivables was ¥35,724 Mil.
Revenue was 19620.277 + 17298.36 + 17855.668 + 16796.327 = ¥71,571 Mil.
Gross Profit was 1624.692 + 1640.553 + 1413.425 + 1478.374 = ¥6,157 Mil.
Total Current Assets was ¥52,327 Mil.
Total Assets was ¥60,796 Mil.
Property, Plant and Equipment(Net PPE) was ¥2,601 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥2,498 Mil.
Total Current Liabilities was ¥44,000 Mil.
Long-Term Debt & Capital Lease Obligation was ¥3,157 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(37993.168 / 80123.113) / (35723.652 / 71570.632)
=0.474185 / 0.499138
=0.95

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(6157.044 / 71570.632) / (6204.835 / 80123.113)
=0.086028 / 0.077441
=1.1109

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (55807.192 + 2610.075) / 64823.403) / (1 - (52326.853 + 2601.282) / 60795.704)
=0.098824 / 0.096513
=1.0239

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=80123.113 / 71570.632
=1.1195

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 2601.282)) / (0 / (0 + 2610.075))
=0 / 0
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(2590.417 / 80123.113) / (2497.947 / 71570.632)
=0.03233 / 0.034902
=0.9263

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((6440.103 + 42264.762) / 64823.403) / ((3157.161 + 43999.558) / 60795.704)
=0.751347 / 0.775659
=0.9687

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(591.873 - 0 - 450.9) / 64823.403
=0.002175

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

CQ Pharmaceutical Holding Co has a M-score of -2.32 suggests that the company is unlikely to be a manipulator.


CQ Pharmaceutical Holding Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of CQ Pharmaceutical Holding Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


CQ Pharmaceutical Holding Co (SZSE:000950) Business Description

Traded in Other Exchanges
N/A
Address
333 Jinshi Avenue, Yubei District, Chongqing, CHN, 400010
CQ Pharmaceutical Holding Co Ltd distributes pharmaceutical products. It is the fixed-point reserve unit for drug and medical equipment of the central and Chongqing industries. The pharmaceutical business sector covers hospitals, pharmaceuticals, healthcare products, hospital sales, commercial wholesale, retail chains, terminal distribution, warehousing logistics and supply chain value-added services. Geographically, the group operates through China.

CQ Pharmaceutical Holding Co (SZSE:000950) Headlines

No Headlines